NBE-Therapeutics AG
Basel / CH-4057 Basel
Die Firma NBE-Therapeutics AG hat aktuell 1 offene Stelle ausgeschrieben.
Basel / CH-4057 Basel
Die Firma NBE-Therapeutics AG hat aktuell 1 offene Stelle ausgeschrieben.
NBE-Therapeutics AG , Basel
1+M
Research Assistant/Associate – (100%, m/f/d)
NBE-Therapeutics is a subsidiary of the Boehringer Ingelheim group: a perfect symbiosis between a rapidly growing biotechnology company and an already well-established big pharma. We are located in Basel, a Swiss city on the river Rhine, known for being an important center of chemical and pharmaceutical industries and renowned for its versatile cultural aspects – a great place to live and work. Our research team is committed to the development of next generation antibody drug conjugates (ADCs) for cancer patients in need for new transformational treatments.
In our Preclinical Pharmacokinetics and Drug Metabolism Department, we are seeking a talented
Research Assistant /Associate – (100%, m/f/d)
for our laboratory dealing with the characterization of new ADC drug candidates.
Job Description
Provide technical support to preclinical research currently ongoing at NBE-Therapeutics. You will be involved in
Your Profile
Your Tasks and Responsibilities
What NBE-Therapeutics AG offers
Who We Are and Our Culture
NBE-Therapeutics is an equal opportunity employer who takes pride in maintaining a diverse and inclusive culture. We embrace diversity of perspectives and strive for an inclusive environment, which benefits our employees, patients and communities.
In January 2021, NBE-Therapeutics joined as a subsidiary specialized in ADCs, the Boehringer Ingelheim group, which focuses on innovative medicines for people and animals since more than 130 years. Boehringer Ingelheim is one of the pharmaceutical industry’s top 20 companies and to this day remains family-owned. Day by day, more than 53’000 employees create value through innovation for the three business areas human pharmaceuticals, animal health and biopharmaceutical contract manufacturing. In 2023, Boehringer Ingelheim achieved a total revenue of nearly 25.6 billion euros. R&D investments, exceeding 5.8 billion euros, corresponded to 22.5% of net sales.
We look forward to receiving your application, including a motivation letter.
Please, send your documents to Write an email referring to job-opening: Ref240712